Home
RXRX
RXRX News

Latest Recursion Pharmaceuticals Inc. (RXRX) News on July 26, 2024

Wall Street Analysts Predict a 43.73% Upside in Recursion Pharmaceuticals (RXRX): Here's What You Should Know

Zacks

10 hours ago

Wall Street Analysts Predict a 43.73% Upside in Recursion Pharmaceuticals (RXRX): Here's What You Should Know

3 Millionaire-Maker Artificial Intelligence (AI) Stocks

Motley Fool

9 days ago

3 Millionaire-Maker Artificial Intelligence (AI) Stocks

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

10 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Is Recursion Pharmaceuticals Stock a Buy?

Motley Fool

13 days ago

Is Recursion Pharmaceuticals Stock a Buy?

1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell

Motley Fool

13 days ago

1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell

These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street

Motley Fool

15 days ago

These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street

MT Newswires

15 days ago

KeyBanc Cuts Price Target on Recursion Pharmaceuticals to $12 From $16, Maintains Overweight Rating

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Zacks

15 days ago

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)

GuruFocus.com

a month ago

Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Premarket Thursday

MT Newswires

a month ago

Recursion Pharmaceuticals Prices $200 Million Stock Offering

Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock

GlobeNewswire

a month ago

Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock

MT Newswires

a month ago

Recursion Pharmaceuticals Plans $200 Million Public Offering

Recursion Announces Proposed Offering of Class A Common Stock

GlobeNewswire

a month ago

Recursion Announces Proposed Offering of Class A Common Stock

Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

a month ago

Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing

Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day

GlobeNewswire

a month ago

Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day

MT Newswires

a month ago

Recursion Pharmaceuticals Insider Sold Shares Worth $278,880, According to a Recent SEC Filing

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

2 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

2 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

2 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

Business Wire

2 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

2 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

2 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

Simply Wall St.

2 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

2 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

2 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

2 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

2 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Nvidia Owns These 4 Stocks. Here’s How They’re Doing.

Barrons.com

2 months ago

Nvidia Owns These 4 Stocks. Here’s How They’re Doing.

MT Newswires

2 months ago

Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing

Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim

Motley Fool

2 months ago

Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

Recursion to Participate in Upcoming Investor Conferences

Cathie Wood Owns These 2 AI Stocks. Should You?

Motley Fool

2 months ago

Cathie Wood Owns These 2 AI Stocks. Should You?

Is Recursion Pharmaceuticals Stock a Millionaire-Maker?

Motley Fool

2 months ago

Is Recursion Pharmaceuticals Stock a Millionaire-Maker?

Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)

GuruFocus.com

2 months ago

Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)

Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock

Insider Monkey

2 months ago

Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock

Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool

GlobeNewswire

2 months ago

Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool

Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board

GlobeNewswire

2 months ago

Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board

2 Stocks That Could 10x by 2035

Motley Fool

2 months ago

2 Stocks That Could 10x by 2035

Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock

Zacks

2 months ago

Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock

Director Blake Borgeson Sells 20,054 Shares of Recursion Pharmaceuticals Inc (RXRX)

GuruFocus.com

2 months ago

Director Blake Borgeson Sells 20,054 Shares of Recursion Pharmaceuticals Inc (RXRX)

What's the Difference Between Biotech Stocks and TechBio Stocks?

Motley Fool

2 months ago

What's the Difference Between Biotech Stocks and TechBio Stocks?

MT Newswires

2 months ago

Recursion Pharmaceuticals Says BioHive-2 AI Supercomputer Completed

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

GlobeNewswire

2 months ago

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

Cathie Wood Is Buying This Under-the-Radar AI Stock

Motley Fool

2 months ago

Cathie Wood Is Buying This Under-the-Radar AI Stock

Recursion Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Recursion Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

3 months ago

Recursion Pharmaceuticals Inc (RXRX) Q1 2024 Earnings: Revenue Surpasses Estimates Amid ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2024 Earnings Call Transcript

MT Newswires

3 months ago

Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises

Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

3 months ago

Recursion Pharmaceuticals: Q1 Earnings Snapshot

Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results

Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks

3 months ago

Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know

Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should Know

Zacks

3 months ago

Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should Know

Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9

GlobeNewswire

3 months ago

Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire

3 months ago

Recursion to Participate in Upcoming Investor Conferences

Jim Cramer is Recommending These 10 Stocks Heading Into May 2024

Insider Monkey

3 months ago

Jim Cramer is Recommending These 10 Stocks Heading Into May 2024

Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program

GlobeNewswire

3 months ago

Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program

Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves

Motley Fool

3 months ago

Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves

Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors

Zacks

3 months ago

Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors

3 Millionaire-Maker Biotech Stocks

Motley Fool

3 months ago

3 Millionaire-Maker Biotech Stocks

Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know

Zacks

3 months ago

Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know

Where Will Recursion Pharmaceuticals Be in 5 Years?

Motley Fool

3 months ago

Where Will Recursion Pharmaceuticals Be in 5 Years?

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

GlobeNewswire

3 months ago

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.

Motley Fool

4 months ago

Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.

The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation

Motley Fool

4 months ago

The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation

Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?

Motley Fool

4 months ago

Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 11,447 Shares

GuruFocus.com

4 months ago

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 11,447 Shares

Down -26.36% in 4 Weeks, Here's Why Recursion Pharmaceuticals (RXRX) Looks Ripe for a Turnaround

Zacks

4 months ago

Down -26.36% in 4 Weeks, Here's Why Recursion Pharmaceuticals (RXRX) Looks Ripe for a Turnaround

Recursion to Participate in Upcoming Investor Conference

GlobeNewswire

4 months ago

Recursion to Participate in Upcoming Investor Conference

All You Need to Know About Recursion Pharmaceuticals (RXRX) Rating Upgrade to Buy

Zacks

4 months ago

All You Need to Know About Recursion Pharmaceuticals (RXRX) Rating Upgrade to Buy

Recursion Publishes Annual Environmental, Social and Governance Report

GlobeNewswire

4 months ago

Recursion Publishes Annual Environmental, Social and Governance Report

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares

GuruFocus.com

4 months ago

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares

New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence

Benzinga

4 months ago

New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence

Recursion Pharmaceuticals Inc CFO Michael Secora Sells 50,000 Shares

GuruFocus.com

4 months ago

Recursion Pharmaceuticals Inc CFO Michael Secora Sells 50,000 Shares

Recursion Announces Plans to Open New Office in London

GlobeNewswire

5 months ago

Recursion Announces Plans to Open New Office in London

Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst

Motley Fool

5 months ago

Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community

GlobeNewswire

5 months ago

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?

InvestorPlace

5 months ago

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

Recursion to Participate in Upcoming Investor Conferences

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Simply Wall St.

5 months ago

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today

Motley Fool

5 months ago

Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates

Zacks

5 months ago

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates

Associated Press Finance

5 months ago

Recursion Pharmaceuticals: Q4 Earnings Snapshot

GuruFocus.com

5 months ago

Recursion Pharmaceuticals Inc (RXRX) Reports Mixed Financial Results Amidst Advancements in ...

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire

5 months ago

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Recursion Pharmaceuticals Inc President and COO Tina Marriott Sells 8,000 Shares

GuruFocus.com

5 months ago

Recursion Pharmaceuticals Inc President and COO Tina Marriott Sells 8,000 Shares

These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?

Motley Fool

5 months ago

These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares

GuruFocus.com

5 months ago

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares

Recursion to Host Public L(earnings) Call on February 27

GlobeNewswire

5 months ago

Recursion to Host Public L(earnings) Call on February 27

Double Your Money: 3 Growth Stocks to Grab in 2024

InvestorPlace

5 months ago

Double Your Money: 3 Growth Stocks to Grab in 2024

Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for

Zacks

5 months ago

Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for

Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks.

Motley Fool

5 months ago

Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks.

Get Rich Quick With These 3 AI Stocks to Buy Now

InvestorPlace

5 months ago

Get Rich Quick With These 3 AI Stocks to Buy Now

Share on Social Networks: